IPO round-up: Bone Therapeutics targets Euronext; Presbia, Entellus set terms
This article was originally published in Clinica
Executive Summary
Two 2014 IPO hopefuls have taken a step closer to completing their public offerings: presbyopia correction specialist Presbia and sinus dilation device developer Entellus have both set terms.